| CANDRIAM EQUITIES L BIOTECHNOLOGY R-H CAP EUR | RVI BIOTECNOLOGÍA | 50,74% | 48,98% | 43,10% | · |
| UBS (LUX) EQUITY SICAV - GLOBAL GROWTH SUSTAINABLE (USD) P-ACC | RVI GLOBAL | 21,74% | 46,83% | 43,10% | · |
| UBS (LUX) EQUITY SICAV - ENGAGE FOR IMPACT (USD) Q-ACC | RVI GLOBAL | 18,55% | 46,12% | 43,09% | · |
| UBS MSCI EUROPE SOCIALLY RESPONSIBLE UCITS ETF EUR ACC | RVI EUROPA | 10,31% | 32,80% | 43,09% | · |
| AB SICAV I-EUROPEAN EQUITY PORTFOLIO C USD | RVI EUROPA | 20,69% | 38,23% | 43,08% | 102,08% |
| ALLIANZ GLOBAL EQUITY INSIGHTS IT EUR | RVI GLOBAL | 28,72% | 47,49% | 43,08% | · |
| BGF JAPAN SMALL & MIDCAP OPPORTUNITIES A4 GBP | RVI JAPÓN SMALL/MID CAP | 35,31% | 69,59% | 43,08% | 117,26% |
| M&G (LUX) GLOBAL FLOATING RATE HIGH YIELD FUND USD J ACC | RFI GLOBAL HIGH YIELD | 4,61% | 19,82% | 43,07% | · |
| PRIVILEDGE - AMERICAN CENTURY EMERGING MARKETS EQUITY (USD) I CAP | RVI EMERGENTES | 65,36% | 91,25% | 43,07% | · |
| GREDOS BOLSA INTERNACIONAL, FI | RVI GLOBAL | 20,14% | 43,81% | 43,05% | 109,72% |
